|
Federal Register
Notices > Scheduling Actions - 1999 >
Proposed Placement of Zaleplon into Schedule IV -
Correction
[Federal Register: May 11, 1999 (Volume 64, Number 90)]
[Corrections]
[Page 25405]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr11my99-145]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[DEA-182P]
21 CFR Part 1308
Schedules of Controlled Substances: Proposed
Placement of Zaleplon into Schedule IV
Correction
In proposed rule document 99-11289, beginning on
page 24094 in the issue of Wednesday May 5, 1999, make the following
corrections:
- On page 24094, in the third column, beginning
in the eighth line from the bottom, the sentence "Zaleplon-related
overdoes were also noted during the clinical trials'' is removed.
- On the same page, in the same column, in the
fifth line from the bottom, "overdoes'' should read
"overdoses''.
[FR Doc. C9-11289 Filed 5-10-99; 8:45 am]
BILLING CODE 1505-01-D
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
Back to
Top
Registration
Support
Toll Free Number: 1-800-882-9539
ARCOS
| Career Opportunities | Chemical Program |
Controlled
Substance Schedules | Drugs and
Chemicals of Concern
Electronic Commerce Initiatives | | Federal Register
Notices | Import Export | Links
| Meetings
and Events | NFLIS
Offices &
Directories | On-Line Forms & Applications |
Program
Description | Publications
|
Questions & Answers | Quotas
Reports Required by 21 CFR | Title 21 Regulations & Codified
CSA
Contact Us | Home
| Hot
Items | Site Map | Search | What's New
|
